NCT01630499

Brief Summary

Breast cancer risk, and risk of related health problems (e.g., heart disease), is highest among women with a history of breast cancer (stages 1-3) who are also overweight or obese. The purpose of this study is to compare a tailored nutrition, physical activity, and behavioral weight management program for breast cancer survivors against a widely available commercial weight management program. We hypothesize that an intervention tailored to the unique psychological, nutritional and physical needs of breast cancer survivors will provide superior physiological and psychological benefits compared to an existing commercial program.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
87

participants targeted

Target at P50-P75 for not_applicable breast-cancer

Timeline
Completed

Started Oct 2012

Typical duration for not_applicable breast-cancer

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 22, 2012

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 28, 2012

Completed
3 months until next milestone

Study Start

First participant enrolled

October 1, 2012

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2016

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2016

Completed
Last Updated

September 30, 2016

Status Verified

September 1, 2016

Enrollment Period

3.4 years

First QC Date

June 22, 2012

Last Update Submit

September 28, 2016

Conditions

Keywords

CancerBreast cancerBreast cancer preventionBreast cancer recurrenceWeight lossWeight managementOverweightObesity

Outcome Measures

Primary Outcomes (2)

  • Change in body weight from baseline to post-intervention

    baseline (month 0), post-intervention (month 3)

  • Change in body weight from post-intervention to follow-up

    post-intervention (month 3), follow-up (month 9)

Secondary Outcomes (31)

  • Change in inflammatory/metabolic disease markers associated with breast cancer recurrence from baseline to post-intervention

    baseline (month 0), post-intervention (month 3)

  • Change in HDL Cholesterol from baseline to post-intervention

    baseline (month 0), post-intervention (month 3)

  • Change in blood glucose control from baseline to post-intervention.

    baseline (month 0), post-intervention (month 3)

  • Change in caloric intake from baseline to post-intervention.

    baseline (month 0), post-intervention (month 3)

  • Change in body composition from baseline to post-intervention.

    baseline (month 0), post-intervention (month 3)

  • +26 more secondary outcomes

Study Arms (2)

Tailored Lifestyle Intervention (TLI)

EXPERIMENTAL

Participants randomized to the TLI condition will receive a 3-month weight management program tailored to the specific needs of women in remission from breast cancer.

Behavioral: Tailored Lifestyle Intervention (TLI)

Commercial Weight Loss Program (CLWP)

ACTIVE COMPARATOR

Participants randomized to the CWLP condition will receive a 3-month commercial weight loss program (i.e., Weight Watchers) at no cost.

Behavioral: Commercial Weight Loss Program (CWLP)

Interventions

The intervention is a nutrition, physical activity, and behavioral weight management program that is tailored to the specific needs of breast cancer survivors.

Tailored Lifestyle Intervention (TLI)

This intervention is a generic, widely-available weight management program.

Commercial Weight Loss Program (CLWP)

Eligibility Criteria

Age21 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female
  • Age 21 to 65
  • History of stage 1, 2, or 3 breast cancer
  • Completed primary treatments (chemotherapy, radiation, and/or surgical treatment) for breast cancer (with or without maintenance therapy) within the last 3 months to 5 years of providing consent
  • Be willing/able to attend groups and assessments in Gainesville or Jacksonville
  • BMI of 27 to 45 kg/m2
  • Weight-stable, i.e., not lost/gained ≥ 10 lbs in the preceding 6 months, or since the end of primary treatment

You may not qualify if:

  • History of bariatric surgery
  • Pregnant, lactating, or planning on becoming pregnant in next 12 months.
  • Irritable bowel syndrome
  • Serious infectious disease
  • Chronic malabsorption syndrome
  • Uncontrolled angina within the past 6 months
  • History of musculo-skeletal or chronic lung diseases that limit physical activity
  • Serum creatinin \> 1.5 mg/dL
  • At-rest blood pressure \> 140/90 mg/Hg
  • Myocardial infarction
  • Stroke
  • Congestive heart failure
  • Chronic hepatitis
  • Cirrhosis
  • Chronic pancreatitis
  • +11 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Florida

Gainesville, Florida, 32611, United States

Location

University of North Florida

Jacksonville, Florida, 32224, United States

Location

Related Publications (16)

  • Pharoah PD, Day NE, Duffy S, Easton DF, Ponder BA. Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer. 1997 May 29;71(5):800-9. doi: 10.1002/(sici)1097-0215(19970529)71:53.0.co;2-b.

    PMID: 9180149BACKGROUND
  • McTiernan A. Behavioral risk factors in breast cancer: can risk be modified? Oncologist. 2003;8(4):326-34. doi: 10.1634/theoncologist.8-4-326.

    PMID: 12897329BACKGROUND
  • King MC, Marks JH, Mandell JB; New York Breast Cancer Study Group. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science. 2003 Oct 24;302(5645):643-6. doi: 10.1126/science.1088759.

    PMID: 14576434BACKGROUND
  • Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003 Apr 24;348(17):1625-38. doi: 10.1056/NEJMoa021423.

    PMID: 12711737BACKGROUND
  • Berclaz G, Li S, Price KN, Coates AS, Castiglione-Gertsch M, Rudenstam CM, Holmberg SB, Lindtner J, Erien D, Collins J, Snyder R, Thurlimann B, Fey MF, Mendiola C, Werner ID, Simoncini E, Crivellari D, Gelber RD, Goldhirsch A; International Breast Cancer Study Group. Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. Ann Oncol. 2004 Jun;15(6):875-84. doi: 10.1093/annonc/mdh222.

    PMID: 15151943BACKGROUND
  • Nichols HB, Trentham-Dietz A, Egan KM, Titus-Ernstoff L, Holmes MD, Bersch AJ, Holick CN, Hampton JM, Stampfer MJ, Willett WC, Newcomb PA. Body mass index before and after breast cancer diagnosis: associations with all-cause, breast cancer, and cardiovascular disease mortality. Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1403-9. doi: 10.1158/1055-9965.EPI-08-1094. Epub 2009 Apr 14.

    PMID: 19366908BACKGROUND
  • Gallicchio L, Kalesan B, Hoffman SC, Helzlsouer KJ. Non-cancer adverse health conditions and perceived health and function among cancer survivors participating in a community-based cohort study in Washington County, Maryland. J Cancer Surviv. 2008 Mar;2(1):12-9. doi: 10.1007/s11764-008-0046-1. Epub 2008 Feb 12.

    PMID: 18648983BACKGROUND
  • Fossa SD, Vassilopoulou-Sellin R, Dahl AA. Long term physical sequelae after adult-onset cancer. J Cancer Surviv. 2008 Mar;2(1):3-11. doi: 10.1007/s11764-007-0039-5. Epub 2007 Dec 4.

    PMID: 18648982BACKGROUND
  • Chen Z, Maricic M, Bassford TL, Pettinger M, Ritenbaugh C, Lopez AM, Barad DH, Gass M, Leboff MS. Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study. Arch Intern Med. 2005 Mar 14;165(5):552-8. doi: 10.1001/archinte.165.5.552.

    PMID: 15767532BACKGROUND
  • Coups EJ, Ostroff JS. A population-based estimate of the prevalence of behavioral risk factors among adult cancer survivors and noncancer controls. Prev Med. 2005 Jun;40(6):702-11. doi: 10.1016/j.ypmed.2004.09.011.

    PMID: 15850868BACKGROUND
  • Bellizzi KM, Rowland JH, Jeffery DD, McNeel T. Health behaviors of cancer survivors: examining opportunities for cancer control intervention. J Clin Oncol. 2005 Dec 1;23(34):8884-93. doi: 10.1200/JCO.2005.02.2343.

    PMID: 16314649BACKGROUND
  • Robien K, Demark-Wahnefried W, Rock CL. Evidence-based nutrition guidelines for cancer survivors: current guidelines, knowledge gaps, and future research directions. J Am Diet Assoc. 2011 Mar;111(3):368-75. doi: 10.1016/j.jada.2010.11.014. No abstract available.

    PMID: 21338735BACKGROUND
  • Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002 Dec 19-26;420(6917):860-7. doi: 10.1038/nature01322.

    PMID: 12490959BACKGROUND
  • Shacter E, Weitzman SA. Chronic inflammation and cancer. Oncology (Williston Park). 2002 Feb;16(2):217-26, 229; discussion 230-2.

    PMID: 11866137BACKGROUND
  • Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010 Jan 20;303(3):235-41. doi: 10.1001/jama.2009.2014. Epub 2010 Jan 13.

    PMID: 20071471BACKGROUND
  • Vance V, Mourtzakis M, McCargar L, Hanning R. Weight gain in breast cancer survivors: prevalence, pattern and health consequences. Obes Rev. 2011 Apr;12(4):282-94. doi: 10.1111/j.1467-789X.2010.00805.x. Epub 2010 Sep 29.

    PMID: 20880127BACKGROUND

MeSH Terms

Conditions

Breast NeoplasmsNeoplasmsWeight LossOverweightObesity

Condition Hierarchy (Ancestors)

Neoplasms by SiteBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesBody Weight ChangesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsOvernutritionNutrition DisordersNutritional and Metabolic Diseases

Study Officials

  • Anne Mathews, PhD, RD

    University of Florida

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 22, 2012

First Posted

June 28, 2012

Study Start

October 1, 2012

Primary Completion

March 1, 2016

Study Completion

July 1, 2016

Last Updated

September 30, 2016

Record last verified: 2016-09

Locations